Frontotemporal Dementia Clinical Trials

Find Frontotemporal Dementia Clinical Trials Near You

Study of the Links Between Self-awareness and Sociocognitive Processes in Neurodegenerative Diseases in People With Frontotemporal Lobar Degeneration, Behavioral Variant and Alzheimer's Disease

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

This monocentric, non-interventional study (SELFSOC) investigates the relationship between self-awareness and social cognition in patients with behavioral variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD). The primary objective is to assess metacognitive efficiency related to social cognitive performance using a computerized facial emotion recognition task combined with confidence judgments. Metacognitive indices (including Mratio) will quantify the correspondence between subjective and objective performance. Thirty-four participants (17 bvFTD, 17 AD; age 50-80; MMSE ≥20) will complete two study visits involving tasks assessing emotion recognition, theory of mind, and memory.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: f
View:

• Diagnosis of possible or probable behavioral variant frontotemporal dementia according to the Rascovsky 2011 criteria (DLFTvc group) OR

• Diagnosis of Alzheimer's disease according to the Jack 2018 criteria, including biomarkers (MA group)

• Mini-Mental State Examination (MMSE) ≥ 20

• Age: 50-80 years

• Sufficient reading and writing proficiency in French to enable completion of the study procedures, in the investigator's opinion

Locations
Other Locations
France
Cognitive Neurology Center, Lariboisière-Fernand Widal Hospital Group, APHP
RECRUITING
Paris
Contact Information
Primary
Emmanuel Cognat, MD PhD
emmanuel.cognat@aphp.fr
+33 (0) 1 40 05 49 54
Time Frame
Start Date: 2026-04
Estimated Completion Date: 2027-12
Participants
Target number of participants: 34
Treatments
Behavioral Variant Frontotemporal Dementia (bvFTD)
Participants diagnosed with behavioral variant frontotemporal dementia according to established clinical criteria (Rascovsky et al., 2011). Patients are aged 50-80 years with mild to moderate disease severity (MMSE ≥20).
Alzheimer's Disease (AD)
Participants diagnosed with Alzheimer's disease based on biomarker-supported criteria (A+T+; Jack et al., 2018). Patients are aged 50-80 years with mild to moderate disease severity (MMSE ≥20).
Sponsors
Collaborators: Institut de psychologie, Université Paris Cité, Laboratoire Mémoire, Cerveau, Cognition
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov